Am 2201
AM-2201 is a synthetic cannabinoid compound that acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. It is used for research and laboratory purposes.
Lab products found in correlation
4 protocols using am 2201
Investigating the Effects of Synthetic Cannabinoids
Characterization of Synthetic Cannabinoids
Characterization of AM-2201 Metabolism
Analytical Characterization of Synthetic Cannabinoids
were purchased from Cayman Chemicals (Ann Arbor, MI).
The non-certified synthetic cannabimimetics; XLR-11 [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone and 5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1Hindole-3-carboxylate) were obtained from Istanbul Police Directorate Crime Laboratory.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!